Toshiba America Medical Systems has introduced for its line of rotational angiography equipment 3D technology that simultaneously visualizes blood vessels and bone. The technology, dubbed three-dimensional fusion digital subtraction angiography
Toshiba America Medical Systems has introduced for its line of rotational angiography equipment 3D technology that simultaneously visualizes blood vessels and bone. The technology, dubbed three-dimensional fusion digital subtraction angiography (3D-FDSA), is designed to optimize neurovascular disease diagnosis and surgical planning on its Infinix i-series of vascular x-ray systems. The fusion capability combines separate reconstructions of blood vessels and bone structures in a single volumetric representation, illustrating intracranial vascular anomalies in the context of surrounding bone structures. It was developed in conjunction with neuroradiologists at Johns Hopkins University.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.